
|Articles|November 15, 2012
Testimony: FDA Commissioner says FDA has limited authority over compounding pharmacies to prevent meningitis outbreak
During a four-hour hearing Nov. 14 led by the chairman of the House Energy and Commerce oversight subcommittee, FDA Commissioner Margaret Hamburg was asked if the FDA could have prevented the recent fungal meningitis outbreak.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
Orforglipron Demonstrates Superior Glycemic Control for Type 2 Diabetes
3
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
4
FDA Approves First 1-Minute Self Test for HIV
5